Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
9.33
+0.15 (1.63%)
Jan 17, 2025, 4:00 PM EST - Market closed
Omeros Employees
Omeros had 198 employees as of December 31, 2023. The number of employees increased by 2 or 1.02% compared to the previous year.
Employees
198
Change (1Y)
2
Growth (1Y)
1.02%
Revenue / Employee
n/a
Profits / Employee
-$679,419
Market Cap
540.67M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
OMER News
- 4 days ago - Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint - Business Wire
- 4 weeks ago - Omeros Antibody Improves Overall Survival In Rare Complication After Stem Cell Transplant, Stock Surges - Benzinga
- 4 weeks ago - Omeros' Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA - Business Wire
- 5 weeks ago - Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting - Business Wire
- 7 weeks ago - Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting - Business Wire
- 2 months ago - Omeros Corporation Provides Update on Progress Toward BLA Resubmission - Business Wire
- 2 months ago - Omeros Corporation (OMER) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Omeros Corporation Reports Third Quarter 2024 Financial Results - Business Wire